市場調查報告書

數位療法的全球市場

Digital Therapeutics

出版商 Global Industry Analysts, Inc. 商品編碼 903083
出版日期 內容資訊 英文 205 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
數位療法的全球市場 Digital Therapeutics
出版日期: 2019年10月01日內容資訊: 英文 205 Pages
簡介

本報告提供全球數位療法市場調查,提供市場概要,各市場區隔·地區的市場規模的變化與預測,市場趨勢及成長要素分析,競爭情形,主要企業的簡介等全面性資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 競爭企業的市場佔有率
    • 競爭企業的市場佔有率:方案
  • 關注企業
  • 市場趨勢和成長要素
  • 全球市場預測

第3章 市場分析

  • 地區市場分析
  • 美國
    • 概要
    • 企業的市場佔有率
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 其他歐洲各國
  • 亞太地區
  • 其他地區

第4章 競爭情形

  • 2MORROW, INC.
  • CANARY HEALTH
  • GINGER.IO
  • LIVONGO HEALTH
  • MANGO HEALTH
  • NOOM INC.
  • OMADA HEALTH, INC.
  • PROPELLER HEALTH
  • PROTEUS DIGITAL HEALTH, INC.
  • WELLDOC

第5章 調查資料

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP11567

Digital Therapeutics market worldwide is projected to grow by US$846.7 Million, driven by a compounded growth of 26.9%. Preventive, one of the segments analyzed and sized in this study, displays the potential to grow at over 27.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$409.2 Million by the year 2025, Preventive will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 27.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$47.1 Million to the region's size and clout in the next 5 to 6 years. Over US$30.1 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Preventive will reach a market size of US$8.8 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 27.2% over the next couple of years and add approximately US$16.9 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include among others, 2Morrow, Inc.; Canary Health Inc.; Ginger.Io, Inc.; Livongo Health; Mango Health Inc.; Noom Inc.; Omada Health, Inc.; Propeller Health; Proteus Digital Health, Inc.; WellDoc, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE 1

II. EXECUTIVE SUMMARY 12

1. MARKET OVERVIEW 12

  • Digital Therapeutics: An Introduction 12
  • Outlook 13
  • Leading Markets 15
  • Factors Impeding Growth 15

2. FOCUS ON SELECT PLAYERS 17

  • Canary Health, Inc. (USA) 17
  • Dthera Sciences (USA) 17
  • Fitbit Health Solutions (USA) 17
  • Livongo Health, Inc. (USA) 18
  • Medtronic, Plc (Ireland) 18
  • Omada Health, Inc. (USA) 18
  • Propeller Health (USA) 19
  • Pear Therapeutics, Inc. (USA) 19
  • Proteus Digital Health, Inc. (USA) 20
  • WellDoc, Inc. (USA) 20

3. MARKET TRENDS & DRIVERS 21

  • Digital Therapeutics Continue to Attract Venture Capital Investments 21
  • Total Venture Capital Funding and Number of Deals in Digital Health Space: 2011-2018 22
  • Digital Health Funding by Segment (in US$ Million): 9M 2019 23
  • Startups Flock the Digital Therapeutics Market 23
  • Select Digital Therapeutics Startups 24
  • Digital Health Unicorn Startups 24
  • Quarterly Investments by Digital Therapeutics Startups in US$ Million: Q1 2018 to Q2 2019 25
  • Pipeline Products Drive Growth Prospects 25
  • A Snapshot of Select DTx Pipeline Products 26
  • Artificial Intelligence and Digital Sensors to Improve Patient Outcomes 27
  • Pharma Majors Foray into Uncharted Territory 27
  • Rising Need for Greater Collaboration between Pharmaceutical Companies and Payers 29
  • Growing Focus on Preventative Healthcare Widens Growth Opportunities 29
  • Overcoming the Stigma of Mental Health through Digital Therapeutics 30
  • Global Number of People Suffering from Mental Disorders (In Million) 31
  • Growing Prevalence of Chronic Diseases to Boost Market Growth 31
  • Worldwide Prevalence of Diabetes: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045 33
  • Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025 34
  • Global Annual Medical Cost of CVD in US$ Billion (2010-2030) 34
  • Digital Therpeutics in Oncology 35
  • Proliferation of Smart Devices Bodes Well for Market Growth 35
  • Smartphone Penetration (as a Proportion of Total Mobile Users) by Region for the Years 2018 and 2025 36
  • United States Mobile Health Apps Market by Type (in %): 2018 & 2025 37
  • Growing Focus on Reducing Healthcare Costs Bolsters Market Growth 37
  • Global Healthcare Expenditure (In US$ Trillion) for the Years 2017, 2019, and 2022 39
  • Aging Population and their Vulnerability to Various Health Conditions: A Vital Growth Driver 39
  • Global Population for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050 40

4. GLOBAL MARKET PERSPECTIVE 41

  • TABLE 1: Digital Therapeutics Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025 41
  • TABLE 2: Digital Therapeutics Market Share Shift across Key Geographies Worldwide: 2019 VS 2025 42
  • TABLE 3: Preventive (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2018-2025 43
  • TABLE 4: Preventive (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2019 VS 2025 44
  • TABLE 5: Treatment/Care (Application) Worldwide Sales in US$ Thousand by Region/Country: 2018-2025 45
  • TABLE 6: Treatment/Care (Application) Market Share Shift across Key Geographies: 2019 VS 2025 46
  • TABLE 7: B2C (Sales Channel) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025 47
  • TABLE 8: B2C (Sales Channel) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025 48
  • TABLE 9: B2B (Sales Channel) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025 49
  • TABLE 10: B2B (Sales Channel) Market Share Breakdown by Region/Country: 2019 VS 2025 50

III. MARKET ANALYSIS 51

  • GEOGRAPHIC MARKET ANALYSIS 51
  • UNITED STATES 51
    • TABLE 11: United States Digital Therapeutics Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025 51
    • TABLE 12: Digital Therapeutics Market Share Breakdown in the United States by Application: 2019 VS 2025 52
    • TABLE 13: United States Digital Therapeutics Market Estimates and Projections in US$ Thousand by Sales Channel: 2018 to 2025 53
    • TABLE 14: United States Digital Therapeutics Market Share Breakdown by Sales Channel: 2019 VS 2025 54
  • CANADA 55
    • TABLE 15: Canadian Digital Therapeutics Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025 55
    • TABLE 16: Canadian Digital Therapeutics Market Share Analysis by Application: 2019 VS 2025 56
    • TABLE 17: Canadian Digital Therapeutics Market Estimates and Forecasts in US$ Thousand by Sales Channel: 2018 to 2025 57
    • TABLE 18: Digital Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Sales Channel for 2019 and 2025 58
  • JAPAN 59
    • TABLE 19: Japanese Demand Estimates and Forecasts for Digital Therapeutics in US$ Thousand by Application: 2018 to 2025 59
    • TABLE 20: Digital Therapeutics Market Share Shift in Japan by Application: 2019 VS 2025 60
    • TABLE 21: Japanese Market for Digital Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Sales Channel for the Period 2018-2025 61
    • TABLE 22: Japanese Digital Therapeutics Market Share Analysis by Sales Channel: 2019 VS 2025 62
  • CHINA 63
    • TABLE 23: Chinese Demand for Digital Therapeutics in US$ Thousand by Application: 2018 to 2025 63
    • TABLE 24: Chinese Digital Therapeutics Market Share Breakdown by Application: 2019 VS 2025 64
    • TABLE 25: Chinese Digital Therapeutics Market Growth Prospects in US$ Thousand by Sales Channel for the Period 2018-2025 65
    • TABLE 26: Chinese Digital Therapeutics Market by Sales Channel: Percentage Breakdown of Sales for 2019 and 2025 66
  • EUROPE 67
    • TABLE 27: European Digital Therapeutics Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025 67
    • TABLE 28: European Digital Therapeutics Market Share Shift by Region/Country: 2019 VS 2025 68
    • TABLE 29: European Digital Therapeutics Addressable Market Opportunity in US$ Thousand by Application: 2018-2025 69
    • TABLE 30: European Digital Therapeutics Market Share Analysis by Application: 2019 VS 2025 70
    • TABLE 31: European Digital Therapeutics Market Estimates and Forecasts in US$ Thousand by Sales Channel: 2018-2025 71
    • TABLE 32: European Digital Therapeutics Market Share Breakdown by Sales Channel: 2019 VS 2025 72
  • FRANCE 73
    • TABLE 33: Digital Therapeutics Quantitative Demand Analysis in France in US$ Thousand by Application: 2018-2025 73
    • TABLE 34: French Digital Therapeutics Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025 74
    • TABLE 35: Digital Therapeutics Market in France by Sales Channel: Estimates and Projections in US$ Thousand for the Period 2018-2025 75
    • TABLE 36: French Digital Therapeutics Market Share Analysis by Sales Channel: 2019 VS 2025 76
  • GERMANY 77
    • TABLE 37: Digital Therapeutics Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025 77
    • TABLE 38: Digital Therapeutics Market Share Distribution in Germany by Application: 2019 VS 2025 78
    • TABLE 39: Digital Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Sales Channel for the Period 2018-2025 79
    • TABLE 40: German Digital Therapeutics Market Share Breakdown by Sales Channel: 2019 VS 2025 80
  • ITALY 81
    • TABLE 41: Italian Demand for Digital Therapeutics in US$ Thousand by Application: 2018 to 2025 81
    • TABLE 42: Italian Digital Therapeutics Market Share Breakdown by Application: 2019 VS 2025 82
    • TABLE 43: Italian Digital Therapeutics Market Growth Prospects in US$ Thousand by Sales Channel for the Period 2018-2025 83
    • TABLE 44: Italian Digital Therapeutics Market by Sales Channel: Percentage Breakdown of Sales for 2019 and 2025 84
  • UNITED KINGDOM 85
    • TABLE 45: United Kingdom Demand Estimates and Forecasts for Digital Therapeutics in US$ Thousand by Application: 2018 to 2025 85
    • TABLE 46: Digital Therapeutics Market Share Shift in the United Kingdom by Application: 2019 VS 2025 86
    • TABLE 47: United Kingdom Market for Digital Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Sales Channel for the Period 2018-2025 87
    • TABLE 48: United Kingdom Digital Therapeutics Market Share Analysis by Sales Channel: 2019 VS 2025 88
  • REST OF EUROPE 89
    • TABLE 49: Rest of Europe Digital Therapeutics Addressable Market Opportunity in US$ Thousand by Application: 2018-2025 89
    • TABLE 50: Rest of Europe Digital Therapeutics Market Share Analysis by Application: 2019 VS 2025 90
    • TABLE 51: Rest of Europe Digital Therapeutics Market Estimates and Forecasts in US$ Thousand by Sales Channel: 2018-2025 91
    • TABLE 52: Rest of Europe Digital Therapeutics Market Share Breakdown by Sales Channel: 2019 VS 2025 92
  • ASIA-PACIFIC 93
    • TABLE 53: Digital Therapeutics Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2018-2025 93
    • TABLE 54: Asia-Pacific Digital Therapeutics Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025 94
    • TABLE 55: Digital Therapeutics Market in Asia-Pacific by Sales Channel: Estimates and Projections in US$ Thousand for the Period 2018-2025 95
    • TABLE 56: Asia-Pacific Digital Therapeutics Market Share Analysis by Sales Channel: 2019 VS 2025 96
  • REST OF WORLD 97
    • TABLE 57: Rest of World Digital Therapeutics Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025 97
    • TABLE 58: Rest of World Digital Therapeutics Market Share Analysis by Application: 2019 VS 2025 98
    • TABLE 59: Rest of World Digital Therapeutics Market Estimates and Forecasts in US$ Thousand by Sales Channel: 2018 to 2025 99
    • TABLE 60: Digital Therapeutics Market in Rest of World: Percentage Share Breakdown of Sales by Sales Channel for 2019 and 2025 100

IV. COMPETITION 101

1. 2MORROW, INC. 101

2. ADHERIUM (NZ) LIMITED 103

3. AKILI INTERACTIVE LABS, INC. 107

4. AMIKO DIGITAL HEALTH LIMITED 109

5. APPLIEDVR, INC. 109

6. ATENTIV LLC 110

7. BIG HEALTH 112

8. BLUE MESA HEALTH 113

9. CANARY HEALTH 114

10. CHRONO THERAPEUTICS, INC. 115

11. CLICK THERAPEUTICS, INC. 116

12. CLOSED LOOP MEDICINE 117

13. COGNOA, INC. 117

14. CUREAPP, INC. 118

15. DAVINCI DIGITAL THERAPEUTICS SRL 119

16. DIABETES DIGITAL MEDIA LTD. 120

17. DIGITAL THERAPEUTICS, INC. 120

18. DTHERA SCIENCES 121

19. FIRSTBEAT TECHNOLOGIES OY 123

20. FITBIT, INC. 123

21. GAIA AG 133

22. GINGER.IO, INC. 135

23. GLOBALMEDIA GROUP, LLC - ORCAS 136

24. GLOOKO AB 138

25. HAPPIFY HEALTH 139

26. HOLMUSK 141

27. JINTRONIX INC. 142

28. JOGO HEALTH 142

29. KAIA HEALTH SOFTWARE GMBH 143

30. KORE DIGITAL HEALTH THERAPEUTICS INC. 143

31. LIMBIX HEALTH, INC. 144

32. LIVONGO HEALTH INC. 145

33. MANGO HEALTH 151

34. MEDTRONIC PLC 152

35. MINDSCIENCES 167

36. MY MHEALTH LIMITED 168

37. NGAGEIT DIGITAL HEALTH 169

38. NOOM INC. 171

39. OMADA HEALTH, INC. 172

40. PALO ALTO HEALTH SCIENCES, INC. (FREESPIRA) 174

41. PEAR THERAPEUTICS, INC. 175

42. PERFINT HEALTHCARE PVT. LTD. 176

43. PROPELLER HEALTH 177

44. PROTEUS DIGITAL HEALTH, INC. 178

45. SALUMEDIA TECNOLOGiAS S.L.U. 179

46. SILVERCLOUD HEALTH 180

47. SORNORMED GMBH 180

48. SUSMED, INC. 181

49. TEVA PHARMACEUTICAL INDUSTRIES LTD. 182

50. VIDA HEALTH 186

51. VIIV HEALTHCARE 187

52. VIRTA HEALTH CORP. 189

53. VOLUNTIS SA 189

54. WELLDOC, INC. 195

55. WELLTHY THERAPEUTICS PVT., LTD. 196

56. WORKIT HEALTH 197

  • DIGITAL THERAPEUTICS MCP11567
  • CONTENTS
Back to Top